Incentive system to support collaborative R&D projects for the creation of new products, processes or systems, or for the introduction of significant improvements in products, processes or systems, relevant in the context of the combat of COVID-19. In this context, Proofs of Concept are supported, aiming at the development of ideas or prototypes that have resulted from R&D projects or that are in progress, and that are close to the market (pre-commercial development). The projects must be developed by firms and R&D institutions in a collaborative way.
Specific issues addressed and anticipated impact
These incentives aim to support collaborative projects (between companies and R&D entities), which respond to the immediate and medium-term needs of the National Health Service (SNS) in the context of COVID-19.
ANI - National Innovation Agency.
- National/Federal government
- Private Sector
- Non-Profit/Civil Society
Issues being addressed:
- Patient care
- Health and safety of responders
- Social effects of the crisis
26 April 2020